VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 207 filers reported holding VERACYTE INC in Q1 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $618 | -0.8% | 27,297 | +12.8% | 0.00% | 0.0% |
| Q2 2023 | $623 | +27.1% | 24,200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $490 | -14.6% | 24,200 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $574 | -99.9% | 24,200 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $395,000 | -16.5% | 24,200 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $473,000 | -32.0% | 24,200 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $696,000 | -18.5% | 24,200 | +10.0% | 0.00% | 0.0% |
| Q4 2021 | $854,000 | -12.1% | 22,000 | +2.8% | 0.00% | -33.3% |
| Q3 2021 | $972,000 | +10.7% | 21,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $878,000 | -17.2% | 21,400 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $1,061,000 | +1.2% | 21,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,048,000 | +114.3% | 21,400 | +41.7% | 0.00% | +100.0% |
| Q3 2020 | $489,000 | -40.8% | 15,100 | -55.7% | 0.00% | -60.0% |
| Q3 2019 | $826,000 | +1047.2% | 34,100 | +162.3% | 0.01% | – |
| Q1 2018 | $72,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 119,680 | $2,672 | 2.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 239,571 | $5,349,620 | 1.62% |
| OBERWEIS ASSET MANAGEMENT INC/ | 597,540 | $13,343,068 | 1.42% |
| ARK Investment Management | 7,593,592 | $169,564,898 | 1.30% |
| Capital Impact Advisors, LLC | 32,969 | $736,198 | 1.23% |
| EFG Asset Management (North America) Corp. | 229,837 | $5,127,663 | 1.22% |
| Parkman Healthcare Partners LLC | 225,872 | $5,043,722 | 0.92% |
| Nikko Asset Management Americas, Inc. | 3,173,576 | $70,770,745 | 0.85% |
| Granite Investment Partners, LLC | 865,770 | $19,332,644 | 0.81% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 175,749 | $3,924,475 | 0.64% |